Global IND Clearances
Plasmid Manufacturing Solutions
Plasmid DNA serves as the critical starting material for cell and gene therapies, mRNA therapeutics, and DNA vaccines, but developers often face challenges with manufacturing scale-up, quality consistency, regulatory compliance, and compressed development timelines. ProBio's GMP plasmid DNA manufacturing services provide scalable, high-quality production and integrated development support to help accelerate programs from early research through clinical and commercial stages.
Plasmid DNA is the foundation of many cell and gene therapies, mRNA therapeutics, and DNA vaccines, yet developers often face challenges with scale-up, manufacturing timelines, regulatory compliance, plasmid quality, and supply chain reliability. As programs move from discovery to clinical and commercial stages, the need for a trusted GMP plasmid manufacturing partner becomes critical.
ProBio's plasmid DNA manufacturing services help biotechnology and pharmaceutical companies overcome these hurdles through rapid turnaround, GMP-compliant production, high-yield proprietary platforms, and integrated support for AAV, lentiviral vector, mRNA, and nucleic acid therapeutic development. Whether you need plasmid DNA for IND-enabling studies, clinical trials, or commercial supply, ProBio delivers scalable solutions designed to accelerate advanced therapy development while maintaining quality, consistency, and regulatory readiness.
End-to-End Plasmid Manufacturing for mRNA, and cell and Gene Therapies
GMP-Principle and GMP Batches
mRNA Plasmid IND Clearances
IND Clearances for DNA Drug
IIT Projects
BLA
Fast Plasmid Turnaround with ProBio
Industrial Leading Timelines
Early clinical plasmids can be produced in as little as two weeks from strain construction to conditional release, while late-stage clinical and commercial GMP plasmids can be released in as little as five weeks from manufacturing. For programs requiring IND-enabling support, ProBio's plasmid CMC services can advance from cell banking to pilot-scale production release in as little as four months.
Guaranteed Delivery
ProBio provides guaranteed plasmid quantity and quality with transparent project execution, helping developers avoid unexpected delays, variability, or hidden costs. Supported by dual manufacturing capabilities in the United States and China, ProBio offers a resilient global supply chain strategy that mitigates risk and ensures reliable delivery throughout clinical and commercial development.
Application-Specific Solutions
Flexible small-scale production from 50 mg to 200 mg to help support early-phase studies while minimizing waste and overproduction. Proprietary platform technologies further optimize performance across applications, enabling reliable, scalable manufacturing from early development through commercialization.
4-Week to Deliver Your Plasmid
Applications and Use Cases
FLYER
GMP Plasmid Manufacturing
Scale up your AAV plasmid production with phase-appropriate quality grades, analytics, and regulatory support.
WHITE
PAPER
Mastering Poly(A) Control
Learn how advanced poly(A) design, monitoring, and process controls help improve mRNA quality, stability, and manufacturing consistency.
Frequently Asked Questions
